MiNK Therapeutics, Inc. - COM NEW (INKT)

CUSIP: 603693201

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / COM NEW
Total 13F shares
46,305
Share change
+46,282
Total reported value
$400,196
Price per share
$8.64
Number of holders
16
Value change
+$399,997
Number of buys
15

Security key

603693201

Report period

Q1 2025

Institutions

16

Top holders

10

Top shareholders of INKT - MiNK Therapeutics, Inc. - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
AGENUS INC
3/4/5
10%+ Owner
class O/S missing
21,772,863
$22,643,778 12 Oct 2023
Garo H. Armen
3/4/5
Director
class O/S missing
1,966,400
$2,045,056 05 May 2023
VANGUARD GROUP INC
13F
Company
class O/S missing
234,182
$163,225 31 Dec 2024
13F
Longbow Finance SA
13F
Company
class O/S missing
166,666
$116,150 31 Dec 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
class O/S missing
101,707
$70,879 31 Dec 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
96,113
$66,998 31 Dec 2024
13F
BlackRock, Inc.
13F
Company
class O/S missing
88,281
$61,523 31 Dec 2024
13F
Christine M. Klaskin
3/4/5
Treasurer
class O/S missing
55,660
$57,886 13 Oct 2021
John Baldoni
3/4/5
Director
class O/S missing
41,193
$42,841 01 Sep 2023
HighTower Advisors, LLC
13F
Company
class O/S missing
50,676
$35,316 31 Dec 2024
13F
STATE STREET CORP
13F
Company
class O/S missing
25,515
$17,781 31 Dec 2024
13F
Greenwich Wealth Management LLC
13F
Company
class O/S missing
10,805
$8,000 31 Dec 2024
13F
NORTHERN TRUST CORP
13F
Company
class O/S missing
11,441
$7,973 31 Dec 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
class O/S missing
10,079
$7,024 31 Dec 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
class O/S missing
5,401
$3,764 31 Dec 2024
13F
UBS Group AG
13F
Company
class O/S missing
2,847
$1,984 31 Dec 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
2,039
$1,420 31 Dec 2024
13F
Covestor Ltd
13F
Company
class O/S missing
1,049
$1,000 31 Dec 2024
13F
OSAIC HOLDINGS, INC.
13F
Company
class O/S missing
1,319
$918 31 Dec 2024
13F
MORGAN STANLEY
13F
Company
class O/S missing
334
$233 31 Dec 2024
13F
JPMORGAN CHASE & CO
13F
Company
class O/S missing
325
$227 31 Dec 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
class O/S missing
247
$172 31 Dec 2024
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
class O/S missing
190
$132 31 Dec 2024
13F
Game Plan Financial Advisors, LLC
13F
Company
class O/S missing
170
$116 31 Dec 2024
13F
Key FInancial Inc
13F
Company
class O/S missing
43
$30 31 Dec 2024
13F
Allworth Financial LP
13F
Company
class O/S missing
2
$3 31 Dec 2024
13F
FMR LLC
13F
Company
class O/S missing
1
$1 31 Dec 2024
13F
Marc Antonius van Dijk
3/4/5
Chief Scientific Officer
class O/S missing
171,078
16 Jan 2024

Institutional Holders of MiNK Therapeutics, Inc. - COM NEW (INKT) as of Q1 2025

As of 31 Mar 2025, MiNK Therapeutics, Inc. - COM NEW (INKT) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,305 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, OSAIC HOLDINGS, INC., Tower Research Capital LLC (TRC), Covestor Ltd, and JPMORGAN CHASE & CO. This page lists 16 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2025 Across Filers

Q4 2025 holders
23
Q1 2025 holders
16
Holder diff
-7
Investor Q4 2025 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .